Role of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor

Cancer and Metastasis Reviews

Volumn 22, Issue 2-3, 2003, Pages 223-236

  Kataoka, Hiroaki ^a   Miyata, Shiro ^a   Uchinokura, Shunro ^a   Itoh, Hiroshi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

HAI 1; Hepatocyte growth factor; HGF activator; HGF activator inhibitor; Invasive growth; Scatter factor

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR 7; DIMER; HEPATOCYTE GROWTH FACTOR ACTIVATOR; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 1; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR 2; KALLIKREIN; MATRIPTASE; MEMBRANE PROTEIN; PLASMIN; PROTEIN PRECURSOR; SCATTER FACTOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; TRYPSIN; UNCLASSIFIED DRUG; VALINE; HGF ACTIVATOR; SPINT1 PROTEIN, HUMAN;

CANCER GROWTH; CANCER INVASION; CELL ACTIVATION; CELL FUNCTION; CELL SURFACE; ENZYME ACTIVATION; HISTOPATHOLOGY; HUMAN; KRINGLE DOMAIN; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TISSUE INJURY; TISSUE REGENERATION; TUMOR; TUMOR CELL; ANIMAL; CELL MEMBRANE; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CELL MEMBRANE; HEPATOCYTE GROWTH FACTOR; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASMS; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 0038026134     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023051500010     Document Type: Review

References (96)

1. Gohda E, Tsubouchi H, Nakayama H, Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 81: 414-419, 1988
2. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T: Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224: 311-316, 1987
3. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242, 1987
4. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W: Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005, 1991
5. Naldini L, Weidner KM, Vigna E, Gaudino G, Bardelli A, Ponzetto C, Narsimhan RP, Hartmann G, Zarnegar R, Michalopoulos W, Birchmeier W. Comoglio PM: Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867-2878, 1991
6. Zarnegar R, Michalopoulos GK: The many faces of hepatocyte growth factor: From hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180, 1995
7. Matsumoto K, Nakamura T: Emerging multipotent aspects of hepatocyte growth factor. J Biochem 119: 591-600, 1996
8. Trusolino L, Comoglio PM: Scatter-factor and semaphoring receptors: Cell signaling for invasive growth. Nat Rev Cancer 2: 289-300, 2002
9. Danilkovitch-Miagkova A, Zbar B: Dysregulation of met receptor tyrosine kinase activity in invasive tumors. J Clin Invest 109: 863-867, 2002
10. Bellusci S, Moens G, Gaudino G, Comoglio P, Nakamura T, Thiery JP, Jouanneau J: Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9: 1091-1099, 1994
11. Rong S, Segal S, Anver M, Resau JH, Vande Woude GF: Invasiveness and metastasis of NIH3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91: 4731-4735, 1994
12. Lamszus K, Jin L, Fuchs A, Shi E, Chowdhury S, Yao Y, Polverini PJ, Laterra J, Goldberg ID, Rosen EM: Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pad of nude mice. Lab Invest 76: 339-353, 1997
13. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T: Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: In vitro analysis of tumor-stromal interactions. Cancer Res 57: 3305-3313, 1997
14. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S: Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 249: 73-77, 1998
15. Jeffers M, Rong S, Vande Wounde GF: Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 16: 1115-1125, 1996
16. Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M: Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP. Int J Cancer 82: 274-281, 1999
17. Abounader R, Ranganathan S, Lal B, Fielding K, Book A. Dietz H, Burger P, Laterra J: Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst 91: 1548-1556, 1999
18. Ferracini R, DiRenzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M, Comoglio PM: The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene 10: 739-749, 1995
19. Moriyama T, Kataoka H, Tsubouchi H, Koono M: Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro. FEBS Lett 372: 78-82, 1995
20. Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B: Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Diff 7: 263-270, 1996
21. Parr C, Jiang WG: Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 19: 857-863, 2001
22. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, Comoglio PM: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833, 1992
23. Gak E, Taylor WG. Chan AML, Rubin JS: Processing of hepatocyte growth factor to the heterodimeric form is required for biological activity. FEBS Lett 311: 17-21, 1992
24. Naka D, Ishii T, Yoshiyama Y, Miyazawa K, Hara H, Hishida T, Kitamura N: Activation of hepatocyte growth factor by proteolytic conversion of single chain form to a heterodimer. J Biol Chem 267: 20114-20119, 1992
25. Miyazawa K, Shimomura T, Naka D, Kitamura N: Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem 269: 8966-8970, 1994
26. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR, Prat M, Maggi G, Arena N, Natali PG, Comoglio PM, DiRenzo MF: Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer 74: 1862-1868, 1996
27. Kataoka H, Hamasuna R, Itoh H, Kitamura N, Koono M: Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res 60: 6148-6159, 2000
28. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N: Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J Biol Chem 268: 10024-10028, 1993
29. Shimomura T, Miyazawa K, Komiyama Y, Hiraoka H, Naka D, Morimoto Y, Kitamura N: Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator. Eur J Biochem 229: 257-261, 1995
30. Mars WM, Zarnegar R, Michalopoulos GK: Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 143: 949-958, 1993
31. Mars WM, Kim TH, Stolz DB, Liu ML, Michalopoulos GK: Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor. Cancer Res 56: 2837-2843, 1996
32. Mizuno K, Takehara T, Nakamura T: Proteolytic activation of a single-chain precursor of hepatocyte growth factor by extracellular serine-protease. Biochem Biophys Res Commun 189: 1631-1638, 1992
33. Naldini L, Vigna E, Bardelli A, Follenzi A, Galimi F, Comoglio PM: Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controled by a stoichiometric reaction. J Biol Chem 270: 603-611, 1995
34. Lee SL, Dickson RB, Lin CY: Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, and epithelial membrane serine protease. J Biol Chem 275: 36720-36725, 2000
35. Matsubara Y, Ichinose M, Yahagi N, Tsukada S, Oka M, Miki K, Kimura S, Omata M, Shiokawa K, Kitamura N, Kaneko Y, Fukamachi, H: Hepatocyte growth factor activator: A possible regulator of morphogenesis during fetal development of the rat gastrointestinal tract. Biochem Biophys Res Commun 253: 477-484, 1998
36. Itoh H, Hamasuna R, Kataoka H, Yamauchi M, Miyazawa K, Kitamura N, Koono M: Mouse hepatocyte growth factor activator gene: Its expression not only in the liver but also in the gastrointestinal tract. Biochim Biophys Acta 1491: 295-302, 2000
37. van Adelsberg JS, Sehgal S, Kukes A, Brady C, Barasch J, Yang J, Huan Y: Activation of HGF by endogenous HGF activator is required for metanephric kidney morphogenesis in vitro. J Biol Chem 276: 15099-15106, 2001
38. Hayashi T, Abe K, Sakurai M, Itoyama Y: Inductions of hepatocyte growth factor and its activator in rat brain with permanent middle cerebral artery occlusion. Brain Res 799: 311-316, 1998
39. Yamazaki M, Tsuboi R, Lee YR, Ishidoh K, Mitsui S, Ogawa H: Hair cycle-dependent expression of hepatocyte growth factor (HGF) activator, other proteinases, and proteinase inhibitors correlates with the expression of HGF in rat hair follicles. J Investig Dermatol Sym Proc 4: 312-315, 1999
40. Nagata K, Hirono S, Kataoka H, Moriuchi A, Shimomura T, Hori T, Hayashi K, Koono M, Kitamura N, Tsubouchi H: Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type I in human hepatocellular carcinoma. Biochem Biophys Res Commun 289: 205-211, 2001
41. Miyazawa K, Wang Y, Minoshima S, Shimizu N, Kitamura N: Structural organization and chromosomal localization of the human hepatocyte growth factor activator gene. Eur J Biochem 258: 355-361, 1998
42. Shimomura T, Kondo J, Ochiai M, Naka D, Miyazawa K, Morimoto Y, Kitamura N: Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem 268: 22927-22932, 1993
43. Miyazawa K, Shimomura T, Kitamura N: Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J Biol Chem 271: 3615-3618, 1996
44. Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650-1659, 1986
45. Kataoka H, Uchino H, Asada Y, Hatakeyama K, Nabeshima K, Sumiyoshi A, Koono M: Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int J Cancer 72: 878-884, 1997
46. Shimomura T, Ochiai M, Kondo J, Morimoto Y: A novel protease obtained from FBS-containing culture supernatant, that processes single-chain form hepatocyte growth factor to two chain form in serum-free culture. Cytotechnology 8: 219-229, 1992
47. Lin CY, Anders J, Johnson M, Sang QA, Dickson RB: Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem 274: 18231-18236, 1999
48. Takeuchi T, Shuman MA, Craik CS: Reverse biochemistry: Use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci USA 96: 11054-11061, 1999
49. Satomi S, Yamasaki Y, Tsuzuki S, Hitomi Y, Iwanaga T, Fushiki T: A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover. Biochem Biophys Res Commun 287: 995-1002, 2001
50. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, Craik CS: Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275: 26333-26342, 2000
51. Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin CY, Taniguchi N: Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding β1-6GlcNAc branching. J Biol Chem 277: 16960-16967, 2002
52. Oberst M, Anders J, Xie B, Singh B, Ossandon M, Johnson M, Dickson RB, Lin CY: Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol 158: 1301-1311, 2001
53. Oberst MD, Johnson MD, Dickson RB, Lin CY, Singh B, Stewart M, Williams A, al-Nafussi A, Smyth JF, Gabra H, Sellar GC: Expression of the serine protease matriptase andn its inhibitor HAI-1 in epithelial ovarian cancer: Correlation with clinical outcome and tumor clinicopathological parameters. Clin Cancer Res 8: 1101-1107, 2002
54. List K, Haudenschild CC, Szabo R, Cehn WJ, Wahl SM, Swaim W, Engelholm LH, Behrendt N, Bugge TH: Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21: 3765-3779, 2002
55. Shimomura T, Denda K, Kitamura A, Kawaguchi T, Kito M, Kondo J, Kagaya S, Qin L, Takata H, Miyazawa K, Kitamura N: Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 272: 6370-6376, 1997
56. Kawaguchi T, Qin L, Shimomura T, Kondo J, Matsumoto K, Denda K, Kitamura N: Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J Biol Chem 272, 27558-27564, 1997
57. Marlor CW, Delaria KA, Davis G, Muller DK, Greve JM, Tamburini PP: Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains. J Biol Chem 272: 12202-12208, 1997
58. Müller-Pillasch F, Wallrapp C, Bartels K, Varga G, Friess H, Büchler M, Adler G, Gress TM: Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer. Biochim Biophys Acta 1395: 88-95, 1998
59. Kataoka H, Itoh H, Koono M: Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol Int 52: 89-102, 2002
60. Delaria KA, Muller DK, Marlor CW, Brown JE, Das RC, Roczniak SO, Tamburini PP: Characterization of placental bikunin, a novel human serine protease inhibitor. J Biol Chem 272: 12209-12214, 1997
61. Itoh H, Yamauchi M, Kataoka H, Hamasuna R, Kitamura N, Koono M: Genomic structure and chromosomal localization of the human hepatocyte growth factor activator inhibitor type 1 and 2 genes. Eur J Biochem 267: 3351-3359, 2000
62. Itoh H, Kataoka H, Hamasuna R, Kitamura N, Koono M: Hepatocyte growth factor activator inhibitor type 2 lacking the first Kunitz-type serine proteinase inhibitor domain is a predominant product in mouse but not in human. Biochem Biophys Res Commun 255: 740-748, 1999
63. Qin L, Denda K, Shimomura T, Kawaguchi T, Kitamura N: Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 2. FEBS Lett 436: 111-114, 1998
64. Kataoka H, Itoh H, Nuki Y, Hamasuna R, Naganuma S, Kitamura N, Shimomura T: Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator. Biochem Biophys Res Commun 290: 1096-1100, 2002
65. Denda K, Shimomura T, Kawaguchi T, Miyazawa K, Kitamura N: Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem 277: 14053-14059, 2002
66. Lin CY, Anders J, Johnson M, Dickson RB: Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274: 18237-18242, 1999
67. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, Kitamura N, Miyazawa K, Koono M: Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 275: 40453-40462, 2000
68. Yamauchi M, Itoh H, Naganuma S, Koono M, Hasui Y, Osada Y, Kataoka H: Expression of hepatocyte growth factor activator inhibitor type 2 (HAI-2) in human testis: Identification of a distinct transcription start site for the HAI-2 gene in testis. Biol Chem 383: 1953-1957, 2002
69. Kataoka H, Uchino H, Denda K, Kitamura N, Itoh H, Tsubouchi H, Nabeshima K, Koono M: Evaluation of hepatocyte growth factor activator inhibitor expression in normal and malignant colonic mucosa. Cancer Lett 128: 219-227, 1998
70. Kataoka H, Suganuma T, Shimomura T, Itoh H, Kitamura N, Nabeshima K, Koono M: Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 47: 673-682, 1999
71. Kataoka H, Meng JY, Itoh H, Hamasuna R, Shimomura T, Suganuma T, Koono M: Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta. Histochem Cell Biol 114: 469-475, 2000
72. Itoh H, Kataoka H, Tomita M, Hamasuna R, Nawa Y, Kitamura N, Koono, M: Up-regulation of hepatocyte growth factor activator inhibitor type-1 but not type-2 along with regeneration of intestinal mucosa. Am J Physiol 278: G635-G643, 2000
73. Matsumoto K, Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 239: 639-644, 1997
74. Itoh H, Kataoka H, Meng JY, Hamasuna R, Kitamura N, Koono M: Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/ placental bikunin genes and their promoters. Biochim Biophys Acta 1519: 92-95, 2001
75. Kataoka H, Itoh H, Hamasuna R, Meng JY, Koono M: Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: Roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Hum Cell 14: 83-93, 2001
76. Shimomura T, Denda K, Kawaguchi T, Matsumoto K, Miyazawa K, Kitamura N: Multiple sites of proteolytic cleavage to release soluble forms of hepatocyte growth factor activator inhibitor type 1 from a transmembrane form. J Biochem 126: 821-828, 1999
77. Benaud C, Dickson RB, Lin CY: Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem 268: 1439-1447, 2001
78. Okajima A, Miyazawa K, Naitoh Y, Inoue K, Kitamura N: Induction of hepatocyte growth factor activator messenger RNA in the liver following tissue injury and acute inflammation. Hepatology 25: 97-102, 1997
79. Tang W, Miyazawa K, Kitamura N: Hepatocyte growth factor remains as an inactive single chain after partial hepatectomy or unilateral nephrectomy. FEBS Lett 362: 220-224, 1995
80. Kinoshita Y, Kishi K, Asahara M, Matasushima Y, Wang HY, Miyazawa K, Kitamura N, Chiba T: Production and activation of hepatocyte growth factor during the healing of rat gastric ulcers. Digestion 58: 225-231, 1997
81. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, Matsumura M, Kaneko N, Terano A, Nakamura T, Omata, M: Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 95: 1994-2003, 1995
82. Tackels-Horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, Vogt LM, Boland JF, Scherf U, Vockley JG: Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling. Cancer 92: 395-405, 2001
83. Kataoka H, Itoh H, Uchino H, Hamasuna R, Kitamura N, Nabeshima K, Koono M: Conserved expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin in human colorectal carcinomas. Cancer Lett 148: 127-134, 2000
84. Hamasuna R, Kataoka H, Meng JY, Itoh H, Moriyama T, Wakisaka S, Koono M: Reduced expression of hepatocyte growth factor activator inhibitor type-2/placental bikunin (HAI-2/PB) in human glioblastomas: Implication for anti-invasive role of HAI-2/PB in glioblastoma cells. Int J Cancer 93: 339-345, 2001
85. Mitchell KJ, Pinson KI, Kelly OG, Brennan J, Zupicich J, Scherz P, Leighton PA, Goodrich LV, Lu X, Avery BJ, Tate P, Dill K, Pangilinan E, Wakenight P, Tessier-Lavigne M, Skarnes W: Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet 28: 241-249, 2001
86. Lakubczak JL, Larochelle WJ, Merlino G: NK1, a natural splice variant of hepatocyte frwoth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol 18: 1275-1283, 1998
87. Otsuka T, Jakubczak J, Vieira W, Bottaro DP, Breckenridge D, Larochelle WJ, Merlino G: Disassociation of Met-mediated biological responses in vivo: The natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol 20: 2055-2065, 2000
88. Yu Y, Merlino G: Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model. Cancer Res 62: 2951-2956, 2002
89. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B: Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997
90. Wang R, Kobayashi R, Bishop JM: Cellular adhesion elicits ligand-independent activation of the Met cell-surface receptor. Proc Natl Acad Sci USA 93: 8425-8430, 1996
91. Taher TE, van der Voort R, Smit L, Keehnen RM, Schilder-Tol EJ, Spaargaren M, Pals ST. Cross-talk between CD44 and c-Met in B cells. Curr Top Microbiol Immunol 246: 31-37, 1999
92. Suzuki M, Kobayashi H, Kanayama N, Nishida T, Takigawa M, Terao T: CD44 stimulation by fragmented hyaluronic acid induces upregulation and tyrosine phosphorylation of c-Met receptor protein in human chondrosarcoma cells. Biochim Biophys Acta 1591: 37-44, 2002
93. Jo M, Stolz DB, Esplen JE, Dorko K, Michalopoulos GK, Strom SC: Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells. J Biol Chem 275: 8806-8811, 2000
94. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373: 699-702, 1995
95. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373: 702-705, 1995
96. Bladt F, Rlethmacher D, Isenmann S, Aguzzi A, Birchmeier C: Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376: 768-771, 1995